COLORADO SPRINGS, Colo.,
Feb. 5, 2015 /PRNewswire/
-- Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company
specializing in cannabis formulation-based drug development and
related consulting, today applauds US Surgeon General Vivek Murphy who announced yesterday in an
interview on 'CBS This Morning' that "we have some preliminary data
showing that for certain medical conditions and symptoms that
marijuana can be helpful." Surgeon General Vivek also said
that scientific data should drive federal medical cannabis policy,
and he is "very interested to see where that data takes us."
"Surgeon General Murphy's statement speaks for itself:
medical cannabis is now solidly in the mainstream of medical
research, as cannabis treatments undoubtedly demonstrate usefulness
in treating various critical ailments," said Chad S. Johnson, Esq., Director, COO and General
Counsel of Cannabis Science, Inc. "The Surgeon General's
public statement on CBS looks to be a long-awaited political and
legal 'game changer' on the federal level for patients in need of
cannabinoid medicine."
Please see Surgeon General Vivek's unprecedented remarks at the
following link: U.S. Surgeon General Backs Medical
Marijuana.
To learn more about Cannabis Science, please see the Company's
website and recent announcements at the following link:
www.cannabisscience.com.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique
understanding of metabolic processes to provide novel treatment
approaches to a number of illnesses for which current treatments
and understanding remain unsatisfactory. Cannabinoids have an
extensive history dating back thousands of years, and currently,
there are a growing number of peer-reviewed scientific publications
that document the underlying biochemical pathways that cannabinoids
modulate. The Company works with leading experts in drug
development, medicinal characterization, and clinical research to
develop, produce, and commercialize novel therapeutic approaches
for the treatment for illnesses caused by infections as well as for
age-related illness. Our initial focus is on skin cancers and
neurological conditions.
Forward-Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
words such as "anticipate," "seek," intend," "believe," "estimate,"
"expect," "project," "plan," or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Some or all of the events
or results anticipated by these forward-looking statements may not
occur. Factors that could cause or contribute to such differences
include the future U.S. and global economies, the impact of
competition, and the Company's reliance on existing regulations
regarding the use and development of cannabis-based drugs. Cannabis
Science, Inc., does not undertake any duty nor does it intend to
update the results of these forward-looking statements.
Cannabis Science, Inc
Raymond
C. Dabney
Director, President & CEO, Co-Founder
raymond@cannabisscience.com
Tel: 1.310.650.3788
Chad S. Johnson, Esq.
Director, COO & General Counsel
www.cannabisscience.com
Tel: 1.888.889.0888
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cannabis-science-reports-cbs-this-morning-interview-us-surgeon-general-believes-medical-cannabis-can-be-helpful-and-suggests-federal-policy-should-be-driven-by-scientific-data-300031458.html
SOURCE Cannabis Science, Inc.